Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
36 hedge funds and large institutions have $146M invested in Decibel Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $168M → $146M (-$22.2M)
22% less funds holding
Funds holding: 46 → 36 (-10)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.93M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$328K |
| 3 |
ACA
Atlas Capital Advisors
Jackson,
Wyoming
|
+$177K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$171K |
| 5 |
E
Ergoteles
New York
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$5.75M |
| 2 |
ZP
Zimmer Partners
New York
|
-$430K |
| 3 |
JP Morgan Chase
New York
|
-$392K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$373K |
| 5 |
Morgan Stanley
New York
|
-$361K |
DBTX Hedge Fund Activity: Q3 2021 in Review
36 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q3 2021, worth a combined $146M — down 13% from $168M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of DBTX and 4 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $1.93M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $5.75M sold.
- 36 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q3 2021, down from 46 in Q2 2021.
- Funds reported $146M of Decibel Therapeutics, Inc. Common Stock stock for Q3 2021, down 13% quarter-over-quarter.
- 4 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q3 2021 and 14 closed out, a net change of -10 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $1.93M added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q3 2021 was Janus Henderson Group, an estimated $5.75M sold.
Based on aggregated 13F filings for Q3 2021.